Home › Funds › Samsara BioCapital, LLC › SEPN
Samsara BioCapital, LLC position in SEPN
SEPTERNA INC · Health Care
Samsara BioCapital, LLC reported holding 3,149,128 shares of SEPN (SEPTERNA INC) in its Q2 2026 13F filing — a position valued at US$105.5M, representing 8.66% of its reported portfolio and ranking #4 among its reported holdings. Samsara BioCapital, LLC has disclosed SEPN holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Samsara BioCapital, LLC's SEPN position evolved
Samsara BioCapital, LLC first disclosed a stake in SEPN in Q4 2024 at 2,768,520 shares (US$63.4M). The position peaked in Q2 2026 at 3,149,128 shares, worth US$105.5M. Across 7 filings, Samsara BioCapital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 3,149,128 shares valued at US$105.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 2.77M | $63.40M | New |
| Q1 2025 | 3.15M | $18.23M | Add |
| Q2 2025 | 3.15M | $33.29M | Hold |
| Q3 2025 | 3.15M | $59.24M | Hold |
| Q4 2025 | 3.15M | $87.80M | Hold |
| Q1 2026 | 3.15M | $75.67M | Hold |
| Q2 2026 | 3.15M | $105.46M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SEPN and 13F data
SEPN (SEPTERNA INC) is a Health Care company. 72 other funds we track also report a position in SEPN — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$234.3M), TRV GP V, LLC (US$208.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$148.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SEPN
- RA CAPITAL MANAGEMENT, L.P. 7.00M sh · $234.29M · Q2 2026
- TRV GP V, LLC 6.22M sh · $208.16M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.43M sh · $148.46M · Q2 2026
- TRV GP VI, LLC 4.21M sh · $141.05M · Q2 2026
- Siren, L.L.C. 1.90M sh · $63.63M · Q2 2026
- Avoro Capital Advisors LLC 1.34M sh · $44.79M · Q2 2026
- First Light Asset Management, LLC 963.26K sh · $32.26M · Q2 2026
- ADAR1 Capital Management, LLC 940.75K sh · $31.51M · Q2 2026
- Casdin Capital 553.27K sh · $18.53M · Q2 2026
- Catalio Capital Management, LP 536.15K sh · $17.96M · Q2 2026
- Kalehua Capital Management LLC 194.54K sh · $6.52M · Q2 2026
- DIADEMA PARTNERS LP 59.70K sh · $2.00M · Q2 2026
More on Samsara BioCapital, LLC
FAQ
How long has Samsara BioCapital, LLC held SEPN?
Samsara BioCapital, LLC has disclosed SEPN holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Samsara BioCapital, LLC's current position in SEPN?
As of Q2 2026, Samsara BioCapital, LLC holds 3.15M shares of SEPN (SEPTERNA INC), valued at $105.46M, representing 8.66% of its reported portfolio and ranking #4.
Has Samsara BioCapital, LLC been buying or selling SEPN?
In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC held unchanged its position in SEPN. The position peaked in Q2 2026 at 3.15M shares.
Which other funds hold SEPN?
Other major institutional holders of SEPN include RA CAPITAL MANAGEMENT, L.P., TRV GP V, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.